These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25542588)

  • 1. Further optimization of the M5 NAM MLPCN probe ML375: tactics and challenges.
    Kurata H; Gentry PR; Kokubo M; Cho HP; Bridges TM; Niswender CM; Byers FW; Wood MR; Daniels JS; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2015 Feb; 25(3):690-4. PubMed ID: 25542588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of the first M5-selective and CNS penetrant negative allosteric modulator (NAM) of a muscarinic acetylcholine receptor: (S)-9b-(4-chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375).
    Gentry PR; Kokubo M; Bridges TM; Kett NR; Harp JM; Cho HP; Smith E; Chase P; Hodder PS; Niswender CM; Daniels JS; Conn PJ; Wood MR; Lindsley CW
    J Med Chem; 2013 Nov; 56(22):9351-5. PubMed ID: 24164599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continued optimization of the M
    McGowan KM; Nance KD; Cho HP; Bridges TM; Conn PJ; Jones CK; Lindsley CW
    Bioorg Med Chem Lett; 2017 Mar; 27(6):1356-1359. PubMed ID: 28237763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Mechanisms of Action of M5 Muscarinic Acetylcholine Receptor Allosteric Modulators.
    Berizzi AE; Gentry PR; Rueda P; Den Hoedt S; Sexton PM; Langmead CJ; Christopoulos A
    Mol Pharmacol; 2016 Oct; 90(4):427-36. PubMed ID: 27461343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Negative Allosteric Modulation of M
    Gould RW; Gunter BW; Bubser M; Matthews RT; Teal LB; Ragland MG; Bridges TM; Garrison AT; Winder DG; Lindsley CW; Jones CK
    ACS Chem Neurosci; 2019 Aug; 10(8):3740-3750. PubMed ID: 31268669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a highly potent, novel M5 positive allosteric modulator (PAM) demonstrating CNS exposure: 1-((1H-indazol-5-yl)sulfoneyl)-N-ethyl-N-(2-(trifluoromethyl)benzyl)piperidine-4-carboxamide (ML380).
    Gentry PR; Kokubo M; Bridges TM; Noetzel MJ; Cho HP; Lamsal A; Smith E; Chase P; Hodder PS; Niswender CM; Daniels JS; Conn PJ; Lindsley CW; Wood MR
    J Med Chem; 2014 Sep; 57(18):7804-10. PubMed ID: 25147929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a Novel Allosteric Site at the M
    Burger WAC; Gentry PR; Berizzi AE; Vuckovic Z; van der Westhuizen ET; Thompson G; Yeasmin M; Lindsley CW; Sexton PM; Langmead CJ; Tobin AB; Christopoulos A; Valant C; Thal DM
    ACS Chem Neurosci; 2021 Aug; 12(16):3112-3123. PubMed ID: 34351123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery, synthesis and characterization of a highly muscarinic acetylcholine receptor (mAChR)-selective M5-orthosteric antagonist, VU0488130 (ML381): a novel molecular probe.
    Gentry PR; Kokubo M; Bridges TM; Cho HP; Smith E; Chase P; Hodder PS; Utley TJ; Rajapakse A; Byers F; Niswender CM; Morrison RD; Daniels JS; Wood MR; Conn PJ; Lindsley CW
    ChemMedChem; 2014 Aug; 9(8):1677-82. PubMed ID: 24692176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of the M
    Vuckovic Z; Gentry PR; Berizzi AE; Hirata K; Varghese S; Thompson G; van der Westhuizen ET; Burger WAC; Rahmani R; Valant C; Langmead CJ; Lindsley CW; Baell JB; Tobin AB; Sexton PM; Christopoulos A; Thal DM
    Proc Natl Acad Sci U S A; 2019 Dec; 116(51):26001-26007. PubMed ID: 31772027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical lead optimization of a pan G(q) mAChR M(1), M(3), M(5) positive allosteric modulator (PAM) lead. Part I: Development of the first highly selective M(5) PAM.
    Bridges TM; Kennedy JP; Cho HP; Breininger ML; Gentry PR; Hopkins CR; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2010 Jan; 20(2):558-62. PubMed ID: 20004578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and Optimization of Potent and CNS Penetrant M
    Bender AM; Cho HP; Nance KD; Lingenfelter KS; Luscombe VB; Gentry PR; Voigtritter K; Berizzi AE; Sexton PM; Langmead CJ; Christopoulos A; Locuson CW; Bridges TM; Chang S; O'Neill JC; Zhan X; Niswender CM; Jones CK; Conn PJ; Lindsley CW
    ACS Chem Neurosci; 2018 Jul; 9(7):1572-1581. PubMed ID: 29678111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and SAR of novel series of imidazopyrimidinones and dihydroimidazopyrimidinones as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5).
    Martín-Martín ML; Bartolomé-Nebreda JM; Conde-Ceide S; Alonso de Diego SA; López S; Martínez-Viturro CM; Tong HM; Lavreysen H; Macdonald GJ; Steckler T; Mackie C; Bridges TM; Daniels JS; Niswender CM; Noetzel MJ; Jones CK; Conn PJ; Lindsley CW; Stauffer SR
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1310-7. PubMed ID: 25683622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and optimization of a novel, selective and brain penetrant M1 positive allosteric modulator (PAM): the development of ML169, an MLPCN probe.
    Reid PR; Bridges TM; Sheffler DJ; Cho HP; Lewis LM; Days E; Daniels JS; Jones CK; Niswender CM; Weaver CD; Conn PJ; Lindsley CW; Wood MR
    Bioorg Med Chem Lett; 2011 May; 21(9):2697-701. PubMed ID: 21194936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic M
    Berizzi AE; Perry CJ; Shackleford DM; Lindsley CW; Jones CK; Chen NA; Sexton PM; Christopoulos A; Langmead CJ; Lawrence AJ
    Neuropsychopharmacology; 2018 Jun; 43(7):1510-1517. PubMed ID: 29483658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a novel 2,3-dimethylimidazo[1,2-a]pyrazine-6-carboxamide M
    Temple KJ; Engers JL; Long MF; Watson KJ; Chang S; Luscombe VB; Jenkins MT; Rodriguez AL; Niswender CM; Bridges TM; Conn PJ; Engers DW; Lindsley CW
    Bioorg Med Chem Lett; 2020 Feb; 30(3):126812. PubMed ID: 31784320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and optimization of a novel series of highly CNS penetrant M4 PAMs based on a 5,6-dimethyl-4-(piperidin-1-yl)thieno[2,3-d]pyrimidine core.
    Wood MR; Noetzel MJ; Engers JL; Bollinger KA; Melancon BJ; Tarr JC; Han C; West M; Gregro AR; Lamsal A; Chang S; Ajmera S; Smith E; Chase P; Hodder PS; Bubser M; Jones CK; Hopkins CR; Emmitte KA; Niswender CM; Wood MW; Duggan ME; Conn PJ; Bridges TM; Lindsley CW
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3029-3033. PubMed ID: 27185330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, structure-activity relationships and biological evaluation of 4,5,6,7-tetrahydropyrazolopyrazines as metabotropic glutamate receptor 5 negative allosteric modulators.
    Hirose W; Kato Y; Yamamoto T; Kassai M; Takata M; Hayashi S; Arai Y; Imai S; Yoshida K
    Bioorg Med Chem Lett; 2016 Aug; 26(16):3866-9. PubMed ID: 27432763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of ML326: The first sub-micromolar, selective M5 PAM.
    Gentry PR; Bridges TM; Lamsal A; Vinson PN; Smith E; Chase P; Hodder PS; Engers JL; Niswender CM; Daniels JS; Conn PJ; Wood MR; Lindsley CW
    Bioorg Med Chem Lett; 2013 May; 23(10):2996-3000. PubMed ID: 23562060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-based virtual screen for the discovery of novel M5 inhibitor chemotypes.
    Geanes AR; Cho HP; Nance KD; McGowan KM; Conn PJ; Jones CK; Meiler J; Lindsley CW
    Bioorg Med Chem Lett; 2016 Sep; 26(18):4487-4491. PubMed ID: 27503678
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.